9 Drug Approvals That Changed the Future of Medicine

Insulin
In 1922, Canadian doctor Frederick Banting discovered that extracting insulin from the pancreas of a dog could help diabetic patients. The insulin was later taken from pigs and cows rather than dogs but some patients had an allergic reaction to it. Genentech created the first synthetic insulin in 1978—recombinant DNA insulin— which didn’t cause an allergic reaction and could be mass produced, changing the lives of diabetes patients the world over. (Source: howstuffworks.com)

MORE: Gene therapy may help babies with type 1 SMA.

Digoxin
Digoxin is derived from the digitalis plant (foxglove) and is a drug used for patients who have an irregular heartbeat or have suffered heart failure. The drug makes the heart beat faster pumping more blood around the body. It was first available as an injection in 1982 and then in a tablet form in 1997. (Source: everydayhealth.com)

MORE: EMA panel recommends the approval of Biogen’s Spinraza in Europe.

Rifampicin (Rifadin)
Rifampicin is one of the leading drugs used to treat tuberculosis. It is an antibiotic that can also be used to treat MRSA where other antibiotics have failed. It was introduced to the world in 1967. (Source: Rifampicin.com)

MORE: Child with SMA dismissed as a “lazy baby” now thriving on Spinraza.

Wendy is a proven blogger and social media manager who has helped to build online communities for businesses and organizations. She currently heads the website’s social outreach online through social media platforms such as Facebook, Twitter, and Pinterest.
×
Wendy is a proven blogger and social media manager who has helped to build online communities for businesses and organizations. She currently heads the website’s social outreach online through social media platforms such as Facebook, Twitter, and Pinterest.

Leave a Comment

Your email address will not be published. Required fields are marked *

Pin It on Pinterest

Share This